Evidence map›Paper›PMID 20881041›Full record

ArticleJournal of virology2010

Comparison of E1A CR3-dependent transcriptional activation across six different human adenovirus subgroups.

Jailal N G Ablack, Peter Pelka, Ahmed F Yousef, Andrew S Turnell, Roger J A Grand, Joe S Mymryk

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jailal N G AblackDepartment of Microbiology and Immunology, The University of Western Ontario, A4-833 London Regional Cancer Program, 800 Commissioners Road E., London, ON N6A 4L6, Canada.
Peter Pelka
Ahmed F Yousef
Andrew S Turnell
Roger J A Grand
Joe S Mymryk
Western University · CACancer Research UK · GB

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The largest E1A isoform of human adenovirus (Ad) includes a C-4 zinc finger domain within conserved region 3 (CR3) that is largely responsible for activating transcription of the early viral genes. CR3 interacts with multiple cellular factors, but its mechanism of action is modeled primarily on the basis of the mechanism for the prototype E1A protein of human Ad type 5. We expanded this model to include a representative member from each of the six human Ad subgroups. All CR3 domains tested were capable of transactivation. However, there were dramatic differences in their levels of transcriptional activation. Despite these functional variations, the interactions of these representative CR3s with known cellular transcriptional regulators revealed only modest differences. Four common cellular targets of all representative CR3s were identified: the proteasome component human Sug1 (hSug1)/S8, the acetyltransferases p300/CREB binding protein (CBP), the mediator component mediator complex subunit 23 (MED23) protein, and TATA binding protein (TBP). The first three factors appear to be critical for CR3 function. RNA interference against human TBP showed no significant reduction in transactivation by any CR3 tested. These results indicate that the cellular factors previously shown to be important for transactivation by Ad5 CR3 are similarly bound by the E1A proteins of other types. This was confirmed experimentally using a transcriptional squelching assay, which demonstrated that the CR3 regions of each Ad type could compete with Ad5 CR3 for limiting factors. Interestingly, a mutant of Ad5 CR3 (V147L) was capable of squelching wild-type Ad5 CR3, despite its failure to bind TBP, MED23, p300/CBP-associated factor (pCAF), or p300/CBP, suggestive of the possibility that an additional as yet unidentified cellular factor is required for transactivation by E1A CR3.

Indexed as

AdenoviridaeAdenoviridae InfectionsAdenovirus E1A ProteinsAnimalsBlotting, WesternCarrier ProteinsCells, CulturedEmbryo, MammalianFibroblastsFluorescent Antibody TechniqueHumansImmunoprecipitationIntracellular Signaling Peptides and ProteinsLuciferasesMediator ComplexMiceAdenovirus E1A ProteinsCarrier ProteinsIntracellular Signaling Peptides and ProteinsLuciferasesMED23 protein, humanMed23 protein, mouseMediator Complexp300-CBP-Associated Factorp300-CBP Transcription FactorsRNA, MessengerSUG1 protein, mammalianTATA-Box Binding ProteinTBP protein, human

Identifiers

PMID20881041
PMCPMC3004344
OpenAlexW2010250205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.